Table of contents

Clinical and epidemiological research

• Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data (11 December, 2008)

  M Dougados, N Schmidely, M Le Bars, C Lafosse, M Schiff, J S Smolen, D Aletaha, P van Riel, G Wells
• Incidence of severe knee and hip osteoarthritis in relation to different measures of body mass: a population-based prospective cohort study (8 May, 2008)

  L S Lohmander, M Gerhardsson de Verdier, J Rollof, P M Nilsson, G Engström
• Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS) (29 April, 2008)

  D D Gladman, C T Schentag, B D M Tom, V Chandran, J Brockbank, C Rosen, V T Farewell
• Recurrence of spondylarthropathy among first-degree relatives of patients: a systematic cross-sectional study (15 April, 2008)

  E Dernis, R Said-Nahal, M-A D’Agostino, P Aegerter, M Dougados, M Breban
• Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study (17 April, 2008)

  I Hafström, K Albertsson, A Boonen, D van der Heijde, R Landewé, B Svensson, for the BARFOT Study Group
• Is birthweight associated with risk of rheumatoid arthritis? Data from a large cohort study (1 July, 2008)

  L A Mandl, K H Costenbader, J F Simard, E W Karlson
• Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry (15 April, 2008)

  G Horneff, F De Bock, I Foeldvari, H J Girschick, H Michels, D Moebius, H Schmeling, and the German and Austrian Paediatric Rheumatology Collaborative Study Group
• Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis (13 May, 2008)

  M Pikwer, U Bergström, J-Å Nilsson, L Jacobsson, G Berglund, C Turesson
• Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis (28 March, 2008)

  M K de Vries, I E van der Horst-Bruinsma, M T Nurmohamed, L A Aarden, S O Stapel, M J L Peters, J C van Denderen, B A C Dijkmans, G J Wolbink
• Sex differences in the association between body mass index and total hip or knee joint replacement resulting from osteoarthritis (26 May, 2008)

  J Franklin, T Ingvarsson, M Englund, L S Lohmander
• Validity of the polymyalgia rheumatica activity score in primary care practice (13 May, 2008)

  A Binard, B Lefebvre, M De Bandt, J-M Berthelot, A Saraux, and the Club “Rhumatismes et Inflammation”
• Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis (28 July, 2008)

  S S Jick, H Choi, L Li, I B McInnes, N Sattar
• Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis (8 May, 2008)

  P Tynjälä, P Vähäsalo, V Honkanen, P Lahdenne
• Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis (29 April, 2008)

  W H Bos, G M Bartelds, M Vis, A R van der Horst, G J Wolbink, R J van de Stadt, D van Schaardenburg, B A C Dijkmans, W F Lems, M T Nurmohamed, L Aarden, D Hamann
• High frequency of venous thromboembolic events in Churg–Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients (17 November, 2008)

  Y Allenbach, R Seror, C Pagnoux, L Teixeira, P Guilpain, L Guillevin, for the French Vasculitis Study Group